V-CO INVESTORS 3 LLC enters VIVOS THERAPEUTICS, INC. with 1.35M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/10/2026ACC: 0002114460-26-000002
10% Owner
Since Mar 2026
1.35M
Baseline shares
100% direct
1.35M
Direct ownership
1 position
4M
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned1.35M
Total
1.35M direct1.35M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.35M | Direct |
| Total | 1.35M | 1.35M direct |
Derivative Holdings3
Series A Common Stock Warrant
DirectUnderlying security
Common Stock
Underlying shares
1.78M
Shares owned
N/A
Exercise price
1.09
Expiration
—
Exercise window
—
Series B Common Stock Warrant
DirectUnderlying security
Common Stock
Underlying shares
1.78M
Shares owned
N/A
Exercise price
1.09
Expiration
—
Exercise window
—
Pre-Funded Warrant
DirectUnderlying security
Common Stock
Underlying shares
429.96K
Shares owned
N/A
Exercise price
0.0001
Expiration
—
Exercise window
—
Total
Underlying
4M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Common Stock Warrant Direct | Common Stock | 1.09 | — | — | 1.78M | N/A |
| Series B Common Stock Warrant Direct | Common Stock | 1.09 | — | — | 1.78M | N/A |
| Pre-Funded Warrant Direct | Common Stock | 0.0001 | — | — | 429.96K | N/A |
| Total | 4M | 0.00 | ||||